National Institute of Allergy and Infectious Diseases (NIAID)

🚀 Dreaming of a career where you can make a difference? Discover the endless possibilities at NIAID with our #recruitment video. Whether you’re passionate about science, administration, or innovation, there is a place for you. Learn more from some of the dedicated public servants who make NIAID a great place to work: https://lnkd.in/e-sD2kX5 #PSRW #NIAIDCareers

Learn about the STOMP #mpox therapeutics trial in the United States and other countries affected by Clade II virus in this video with Dr. Cyrus Javan of the #NIAID Division of AIDS: https://lnkd.in/egxMxnJt

📢 We're hiring! #NIAID is seeking an exceptional leader to serve as chief of the Virology Branch (VB) within the Division of Microbiology and Infectious Diseases (DMID). The chief of VB directs a complex program that promotes basic, translational, and clinical research and advances product development for prominent viral infectious diseases other than HIV. Reporting to the DMID director, the chief oversees efforts to understand the biology and pathogenesis of 200+ viruses across 20+ viral families, including pandemic threats, and shape scientific priorities aligned with NIH, HHS, and broader U.S. and global health goals. Applications are due 11/26. Learn more and #ApplyNow at https://go.nih.gov/9V88FCa #NowHiring #NIAIDCareers #JobOpening #NIAIDResearch

Sharing data is a crucial part in responding to infectious disease outbreaks, including the highly pathogenic avian influenza (HPAI) outbreak caused by the H5N1 virus. Learn more about the role of scientific data sharing and the NIAID programs collecting data to understand and track HPAI: https://go.nih.gov/0Mg160H #NIAIDDataScience Photo Credit: CDC and NIAID

As part of #NIAID’s participatory process to evaluate its #HIV clinical research enterprise and inform future investments, the Institute is sharing priorities to advance HIV therapeutics and care. Scientific goals include fostering the next generation of discoveries that will enable people with HIV—including people who have taken #AntiretroviralTherapy for decades—to experience a typical lifespan with high life quality, free from a chronic medication burden; reducing the incidence of concurrent #tuberculosis and #hepatitis; and ensuring scientific advances can feasibly be scaled to all who stand to benefit. The Institute continues to welcome feedback on these priorities. Learn more: https://go.nih.gov/jZzDneS

A four-gene signature detectable in newborns’ blood at birth predicts before symptom onset whether a baby will develop #sepsis during the first week of life, NIAID-funded researchers report in eBioMedicine. Sepsis is a potentially life-threatening condition that arises when the body's response to infection injures its own tissues and organs. Using the newly discovered genetic signature to identify newborns who will develop sepsis could facilitate early treatment and obviate the need to give #antibiotics to all newborns with suspected sepsis but lacking a definitive diagnosis. Learn more: https://go.nih.gov/JNv2NqO #NeonatalSepsis #NewbornHealth #AMR The University of British Columbia Simon Fraser University Canadian Institutes of Health Research | Instituts de recherche en santé du Canada 📷Credit: NHGRI

Recently, the UN General Assembly high-level meeting on antimicrobial resistance highlighted the ongoing need for decisive action on the growing threat posed by pathogens that are gaining resistance to common treatments. For many patients with antibiotic-resistant infections, finding an antibiotic that will successfully fight the infection can take hours or days of testing—and, researchers suspect, those days may mean the difference in how well the patient recovers. A trial from the NIAID-supported Antibacterial Research Leadership Group (ARLG) is investigating whether a rapid test of antibiotic susceptibility for bacteria growing in blood cultures improves clinical outcomes for patients with sepsis in settings that have high rates of antibiotic-resistant bacterial infections. Learn more: https://go.nih.gov/2jEGFgh

Intramural NIAID Research Opportunities (INRO) allows #postbaccalaureate trainees like Silvia Blanco Rivera to hone their research interests while working with leading experts and gaining career development support. Discover how INRO is empowering the next generation of #biomedical researchers at https://go.nih.gov/GBHCNbR #NIAIDTraining #INRO2025

The Vaccine Research Center (VRC) at #NIAID seeks exceptional #scientists to join as tenure-track investigators. This opportunity is ideal for early-stage investigators who share VRC’s vision for collaboration, mentorship, and the application of transdisciplinary approaches to develop vigorous independent research programs. VRC’s mission is to apply the latest concepts in disease pathogenesis and immunology as well as scientific and technological innovation to design, develop, and manufacture pilot clinical lots and clinically evaluate investigational vaccines, antibody-based products, and other biomedical interventions. Learn more and #ApplyNow at https://go.nih.gov/PemceDd Applications close 12/19. #NIAIDCareers #JobOpening #NIAIDResearch #NIAIDVRC

The NIAID Office of Research Training & Development will host a virtual info session for Intramural NIAID Research Opportunities (INRO) 2025 on November 19. Learn more about this paid #postbaccalaureate fellowship that promotes diversity in the biomedical sciences and how to apply. Register here: https://lnkd.in/dumetNqf #NIAIDTraining #INRO2025